499 related articles for article (PubMed ID: 21838680)
1. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.
Folli F; Corradi D; Fanti P; Davalli A; Paez A; Giaccari A; Perego C; Muscogiuri G
Curr Diabetes Rev; 2011 Sep; 7(5):313-24. PubMed ID: 21838680
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and diabetic complications.
Giacco F; Brownlee M
Circ Res; 2010 Oct; 107(9):1058-70. PubMed ID: 21030723
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
Fiorentino TV; Prioletta A; Zuo P; Folli F
Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
[TBL] [Abstract][Full Text] [Related]
4. Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications.
Johnson EL
Adv Exp Med Biol; 2012; 771():139-54. PubMed ID: 23393677
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia and the pathobiology of diabetic complications.
Aronson D
Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
[TBL] [Abstract][Full Text] [Related]
6. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
7. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease.
Jakus V
Bratisl Lek Listy; 2000; 101(10):541-51. PubMed ID: 11218944
[TBL] [Abstract][Full Text] [Related]
8. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
Rolo AP; Palmeira CM
Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway.
Ying L; Li N; He Z; Zeng X; Nan Y; Chen J; Miao P; Ying Y; Lin W; Zhao X; Lu L; Chen M; Cen W; Guo T; Li X; Huang Z; Wang Y
Cell Death Dis; 2019 Sep; 10(9):665. PubMed ID: 31511499
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological mechanisms of diabetic angiopathy.
Hammes HP
J Diabetes Complications; 2003; 17(2 Suppl):16-9. PubMed ID: 12623164
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.
Kang Q; Yang C
Redox Biol; 2020 Oct; 37():101799. PubMed ID: 33248932
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture.
Cooper ME; El-Osta A; Allen TJ; Watson AMD; Thomas MC; Jandeleit-Dahm KAM
Diabetes; 2018 May; 67(5):785-790. PubMed ID: 29678824
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways.
Mokini Z; Marcovecchio ML; Chiarelli F
Diabetes Res Clin Pract; 2010 Mar; 87(3):313-21. PubMed ID: 20022399
[TBL] [Abstract][Full Text] [Related]
15. Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction.
Kim SH; Kim SH; Choi M; Lee Y; Kim YO; Ahn DS; Kim YH; Kang ES; Lee EJ; Jung M; Cho JW; Williams DR; Lee HC
Cardiovasc Res; 2010 Sep; 87(4):713-22. PubMed ID: 20299332
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.
Madonna R; De Caterina R
Vascul Pharmacol; 2011; 54(3-6):68-74. PubMed ID: 21453786
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia and cardiovascular disease.
Duckworth WC
Curr Atheroscler Rep; 2001 Sep; 3(5):383-91. PubMed ID: 11487449
[TBL] [Abstract][Full Text] [Related]
18. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
Chilelli NC; Burlina S; Lapolla A
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
[TBL] [Abstract][Full Text] [Related]
19. A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.
Babel RA; Dandekar MP
Curr Diabetes Rev; 2021; 17(4):457-473. PubMed ID: 33143626
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
Potenza MA; Gagliardi S; Nacci C; Carratu' MR; Montagnani M
Curr Med Chem; 2009; 16(1):94-112. PubMed ID: 19149564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
